Trimethaphan camsylate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for trimethaphan camsylate and what is the scope of patent protection?
Trimethaphan camsylate
is the generic ingredient in one branded drug marketed by Roche and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for trimethaphan camsylate
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 17 |
| Clinical Trials: | 3 |
| Patent Applications: | 909 |
| DailyMed Link: | trimethaphan camsylate at DailyMed |
Recent Clinical Trials for trimethaphan camsylate
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Vanderbilt University | Phase 1 |
Medical Subject Heading (MeSH) Categories for trimethaphan camsylate
US Patents and Regulatory Information for trimethaphan camsylate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roche | ARFONAD | trimethaphan camsylate | INJECTABLE;INJECTION | 008983-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
